Camber Pharmaceuticals launches generic Methylin
ADHD. Methylphenidate chewable tablets are available in 2.5, 5 and 10mg 100 count bottles. The
Supplier News
J&J Vision intros AI virtual assistant for contact lenses
Johnson & Johnson Vision today introduced Andy, a virtual assistant chatbot powered by artificial intelligence (AI). Andy is designed to help guide U.S. consumers throughout their Acuvue Brand Contact Lens journey – from those considering contact lenses for the first time to long-term wearers.
Dr. Reddy’s aims to widen access to affordable Rxs
Dr. Reddy’s Laboratories Ltd. is building a pathway to long-term future growth on a strong foundation of capabilities. The innovation-focused pharmaceuticals manufacturer is well positioned to adapt to the swiftly changing global market and emerging opportunities in health care.
Pop-Tarts offers two flavors in one pastry
Next month, Pop-Tarts Toaster Pastries is releasing two all-new, ingenious toaster pastries that are said to up the ante when it comes to taste, with two flavors side-by-side in one tart: Frosted Strawberry & Drizzled Cheesecake and Drizzled Sugar Cookie & Frosted Brownie Batter.
“Getting Wiggy” cards from American Greetings offer birthday squeals
American Greetings latest greeting card invention, the “Getting Wiggy” collection, is full of sidesplitting personality.
Suppliers roll out products for a more restful sleep
The problem of too little sleep is as critical as ever. According to a recent Consumer Reports survey, 27% of 4,023 U.S. adults polled said they had trouble falling asleep or staying asleep most nights, and 68% struggled with sleep at least once a week. “Sleep is very important,” says Mary Adekunle,
Shea Moisture Red Palm Oil taking over Curlkit’s April subscription box
This month, Curlkit has collaborated with Shea Moisture and the top hair care brand is exclusively taking over Curlkit’s April 2018 subscription box with its New Red Palm Oil Collection.
Aurobindo receives FDA approval for capecitabine tablets
Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for capecitabine tablets USP, 150 mg, and 500 mg. Aurobindo’s capecitabine tablets USP are an AB-rated generic equivalent to the reference listed drug Xeloda.
GMDC names Tom Duffy VP of member development
Industry veteran Tom Duffy has been named vice president of member development at the Global Market Development Center (GMDC).
Brush Buddies intros new soft toothbrush line
Brush Buddies, the makers of the 90-Day Toothbrush and the award-winning Brush Beatz singing oral care line, comes Caress, an innovative new line of soft, soothing toothbrushes for the sensitive mouth.
Barbasol teams up with The Onion on new ad campaign
After 99 years of pondering what the perfect complement to the country’s most popular shaving cream could be, a light bulb went off at Barbasol: Razors. Being just shy of 100, Barbasol decided to add another 30 years of experience onto its team to help bolster the expansion of its shaving empire by
Bausch + Lomb rolls out Lumify eye drops
Bausch + Lomb recently celebrated the launch of Lumify, a new eye drop product and brand aimed at reducing eye redness, at the Gallery at the Metropolitan Pavilion in Chelsea.
Consumers seek more solutions when it comes to snoring
Snoring is a common problem among all ages and both genders, and it affects approximately 90 million American adults — 37 million on a regular basis. Snoring usually becomes more serious as people age. It can cause disruptions to your own sleep and your bed-partner’s sleep as well.
Mylan adds to growing women’s healthcare portfolio
Global pharmaceutical company Mylan N.V. announced the U.S. launch of Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg, a generic version of Bayer’s Yaz tablets. Mylan Pharmaceuticals received final approval from the U.S.
New Novartis app enhances opthalmology trials
Novartis has launched the FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients.
Walgreens #ItEndsWithUs campaign heads to Chicago
Walgreens announced that its national “#ItEndsWithUs” campaign is coming to Chicago to educate local teens on the opioid epidemic.